SENORX, INC.
11 COLUMBIA, SUITE A
ALISO VIEJO, CA 92656
March 26, 2007
Via EDGAR Transmission and Facsimile
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.W.
Mail Stop 6010
Washington, D.C. 20549
Attn: Perry Hindin
Re: | SenoRx, Inc. |
File No. 333-134466 |
Dear Mr. Hindin:
On behalf of SenoRx, Inc. (the “Company”), we hereby respectfully request that the Securities and Exchange Commission (the “Commission”) take appropriate action to make the Company’s Registration Statement on Form S-1 effective on March 28, 2007 at 4:00 p.m. E.D.S.T. or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the Commission. The Company hereby authorizes David Saul or Elton Satusky of Wilson Sonsini Goodrich & Rosati, P.C., counsel to the Company, to make such request on our behalf.
In connection with the above-captioned Registration Statement, the Company acknowledges that:
• | should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; |
• | the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and |
• | the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceedings initiated by the Commission or any person under the federal securities laws of the United States. |
U.S. Securities and Exchange Commission
Page 2
Please direct any questions regarding this filing to David Saul at (650) 320-4872.
Sincerely, |
/s/ Lloyd H. Malchow |
Lloyd H. Malchow President and Chief Executive Officer |
cc: | Donald Hunt, U.S. Securities and Exchange Commission |
David Saul, Wilson Sonsini Goodrich & Rosati, P.C. |